The new facility is expected to significantly improve access to high-quality medical services for patients across Gujarat and neighbouring regions
The upgrade centres on new machinery and advanced technology designed to expand capacity and sharpen turnaround times in increasingly competitive flexible packaging markets.
At the centre of this shift is Eli Lilly and Company, whose latest investments in China and Japan are helping redefine the next phase of GLP-1 supply strategy
The milestone moves the company closer to its previously announced $120 million US expansion, with groundbreaking slated for late 2026
The first of four planned modules at the new plant is expected to come online by summer 2026
Backed by a multi-hundred-million-dollar investment, the expansion underscores Sanofi’s long-term commitment to India’s thriving life sciences ecosystem
The multimillion-dollar facility combines discovery and early-phase scale-up capabilities with R&D labs and two pilot plants
Lucid-MS represents a potential breakthrough in the treatment of multiple sclerosis
The additional production will raise the installed capacity by 400 million and available capacity by 240 million at the facility
Subscribe To Our Newsletter & Stay Updated
